Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
The N-glycolylated ganglioside NeuGc-GM3 has been described in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but is usually not detected in normal human cells. Our aim was to evaluate the presence of NeuGc-GM3 in pediatric neuroectodermal tumors by immunohistochemis...
Saved in:
Main Authors: | Alejandra M. Scursoni, Laura Galluzzo, Sandra Camarero, Jessica Lopez, Fabiana Lubieniecki, Claudia Sampor, Valeria I. Segatori, Mariano R. Gabri, Daniel F. Alonso, Guillermo Chantada, María Teresa G. de Dávila |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/245181 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
by: Luis E. Fernandez, et al.
Published: (2010-01-01) -
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells
by: Sonia Bergante, et al.
Published: (2018-01-01) -
Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease
by: Wenxuan Wang, et al.
Published: (2025-02-01) -
Melanotic Neuroectodermal Tumor of Infancy in the Maxilla
by: Daniel Falbo Martins de Souza, et al.
Published: (2013-01-01) -
Primitive Neuroectodermal Tumor of the Liver: A Case Report
by: Eduardo Cambruzzi, et al.
Published: (2011-01-01)